Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paulo M G Hoff

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Rare Tumors|December 9, 2010
Rare tumors research in emerging countriesMax S Mano, Roberto J Arai, Paulo M G Hoff
Journal of Thrombosis and Thrombolysis|February 9, 2010
Venous thromboembolism and cancer: a systematic reviewCelso Arrais Rodrigues, Renata Ferrarotto, Roberto Kalil Filho, et al.
Investigational New Drugs|October 23, 2008
Phase II trial of romidepsin (NSC-630176) in previously treated colorectal cancer patients with advanced disease: a Southwest Oncology Group study (S0336)Robert P Whitehead, Cathryn Rankin, Paulo M G Hoff, et al.
Journal of Surgical Oncology|December 5, 2019
Gastric cancer molecular classification and adjuvant therapy: Is there a different benefit according to the subtype?Marcus F K P Ramos, Marina A Pereira, Larissa C Amorim, et al.
The Oncologist|August 8, 2020
Adjuvant Treatment with 5-Fluorouracil and Oxaliplatin Does Not Influence Cardiac Function, Neurovascular Control, and Physical Capacity in Patients with Colon CancerRaphaela V Groehs, Marcelo V Negrao, Ludhmila A Hajjar, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Rare Tumors|December 9, 2010
Rare tumors research in emerging countriesMax S Mano, Roberto J Arai, Paulo M G Hoff
Journal of Thrombosis and Thrombolysis|February 9, 2010
Venous thromboembolism and cancer: a systematic reviewCelso Arrais Rodrigues, Renata Ferrarotto, Roberto Kalil Filho, et al.
Investigational New Drugs|October 23, 2008
Phase II trial of romidepsin (NSC-630176) in previously treated colorectal cancer patients with advanced disease: a Southwest Oncology Group study (S0336)Robert P Whitehead, Cathryn Rankin, Paulo M G Hoff, et al.
Journal of Surgical Oncology|December 5, 2019
Gastric cancer molecular classification and adjuvant therapy: Is there a different benefit according to the subtype?Marcus F K P Ramos, Marina A Pereira, Larissa C Amorim, et al.
The Oncologist|August 8, 2020
Adjuvant Treatment with 5-Fluorouracil and Oxaliplatin Does Not Influence Cardiac Function, Neurovascular Control, and Physical Capacity in Patients with Colon CancerRaphaela V Groehs, Marcelo V Negrao, Ludhmila A Hajjar, et al.
Pageof 1